InvestorsHub Logo

moneycrew

03/11/21 9:22 PM

#152496 RE: 2020trader #152494

They can only wish to do so. Cytodyn will be the SOC for severe to critical.
After this statement from the DSMC that drug is due to fail and Cytodyn will take the mild to moderate treatments as well

"Although VIR-7831 met the initial pre-specified criteria to continue to the next phase of the trial, early sensitivity analyses of the first 300 patients enrolled in the trial have ‘raised concerns’ over the potential benefit of the drug in this setting.

As a result, the independent data and safety monitoring board (DSMB) has recommended that enrolment for the VIR-7831 arm of the trial should be paused while the data matures"

Bye bye